Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

Luminex reports higher Q1 net income, provides guidance for Q2

Luminex Corporation, a biotechnology company, has reported that net income for the first quarter ended March 31, 2015 was $7.45 million, or $0.18 per share, compared to $5.97 million, or $0.14 per share, for the same quarter ended March 31, 2014. For the second quarter of 2015, the company expects revenue to be between $56 million and $58 million.

Published By MarketLine
21 May 2015
NewsWire
NewsWire

OraSure Technologies reports Q1 net income, provides outlook for Q2

OraSure Technologies, Inc. has reported that net income for the first quarter ended March 31, 2015 was $113,000, or $0 per share, compared to a net loss of $5.63 million, or $0.10 loss per share, for the same quarter ended March 31, 2014. For the second quarter of 2015, the company expects consolidated net revenues to be in the range of $29 million to $29.5 million.

Published By MarketLine
21 May 2015
NewsWire
NewsWire

NanoString Technologies reports higher Q1 net loss, provides annual outlook

NanoString Technologies, Inc. has reported that net loss for the first quarter ended March 31, 2015 was $14.89 million, or $0.81 loss per share, compared to a net loss of $11.42 million, or $0.68 loss per share, for the same quarter ended March 31, 2014. For 2015, the company expects total revenue to be in the range of $58 million to $61 million.

Published By MarketLine
21 May 2015
NewsWire
NewsWire

LHC Group reports higher Q1 net income, provides annual outlook

LHC Group, Inc. has reported that net income attributable to the company's common stockholders for the first quarter ended March 31, 2015 was $6.80 million, or $0.39 per share, compared to $4.07 million, or $0.24 per share, for the same quarter ended March 31, 2014. For 2015, the company expects diluted earnings per share to be in the range of $1.55 to $1.70.

Published By MarketLine
21 May 2015
NewsWire
NewsWire

MedAssets reports lower Q1 net income, reaffirms guidance for 2015

MedAssets, Inc., a healthcare performance improvement company, has reported that net income for the first quarter ended March 31, 2015 was $3.35 million, or $0.06 per diluted share, compared to $7.68 million, or $0.12 per diluted share, for the same quarter ended March 31, 2014. For 2015, the company has reaffirmed its total net revenue guidance range to be between $753 million and $767 million.

Published By MarketLine
21 May 2015
NewsWire
NewsWire

Immunomedics Q3 net loss increases

Immunomedics, Inc., a clinical-stage biopharmaceutical company, has reported that net loss attributable to the stockholders for the third quarter ended March 31, 2015 was $11.76 million, or $0.13 loss per share, compared to a net loss attributable to the stockholders of $9.50 million, or $0.11 loss per share, for the same quarter ended March 31, 2014.

Published By MarketLine
21 May 2015
NewsWire
NewsWire

Photocure Q1 net loss decreases

Photocure ASA, a specialty pharmaceutical company, has reported that net loss for the first quarter of 2015 was NOK10.95 million, or NOK0.51 loss per share, compared to a net loss of NOK13.04 million, or NOK0.61 loss per share, for the same quarter of 2014.

Published By MarketLine
21 May 2015
NewsWire
NewsWire

Chemed reports higher Q1 net income, provides guidance for 2015

Chemed Corporation, a provider of hospice and palliative care services, has reported that net income for the first quarter ended March 31, 2015 was $24.54 million, or $1.4 per diluted share, compared to $20.57 million, or $1.12 per diluted share, for the same quarter ended March 31, 2014. For 2015, the company expects adjusted earnings per diluted share to be in the range of $6.5 to $6.7.

Published By MarketLine
21 May 2015
NewsWire
NewsWire

DaVita HealthCare reports net loss for Q1, updates guidance for 2015

DaVita HealthCare Partners Inc. has reported that net loss attributable to the company for the first quarter ended March 31, 2015 was $110.62 million, or $0.52 loss per diluted share, compared to a net income attributable to the company of $183.29 million, or $0.85 per diluted share, for the same quarter ended March 31, 2014. For 2015, the company expects operating income to be in the range of $1.80 billion to $1.92 billion, compared to the prior guidance of $1.75 billion to $1.90 billion.

Published By MarketLine
21 May 2015
NewsWire
NewsWire

Henry Schein reports higher Q1 net income, affirms guidance for 2015

Henry Schein, Inc., a provider of health care products and services, has reported that net income attributable to the company for the first quarter ended March 28, 2015 was $103.45 million, or $1.22 per diluted share, compared to $102.1 million, or $1.18 per diluted share, for the same quarter ended March 29, 2014. For 2015, the company expects adjusted diluted EPS to be in the range of $5.90 to $6.00.

Published By MarketLine
21 May 2015

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.